Search clinical trials for: Localized HER2 Breast Cancer
Total 89382 results
-
Forward Pharmaceuticals Co., Ltd.WuXi ClinicalRecruitingCarcinoma, Non-Small-Cell LungUnited States
-
Shanghai Miracogen Inc.RecruitingMetastatic Urothelial Carcinoma | Locally Advanced Urothelial CancerChina
-
Peking University Cancer Hospital & InstituteRecruiting
-
Shanghai Miracogen Inc.RecruitingAdvanced Solid Tumors | Advanced or Metastatic Gastric Cancer | Advanced or Metastatic Gastroesophageal Junction CancerUnited States
-
Shanghai Chest HospitalRecruitingNon-small-cell Lung CancerChina
-
Second Affiliated Hospital of Guangzhou Medical...Guangdong Zhaotai InVivo Biomedicine Co. Ltd.; Hunan Zhaotai Yongren Medical...RecruitingCancer | Lung Cancer | Immunotherapy | CAR-T CellChina
-
Jazz PharmaceuticalsActive, not recruitingHER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerUnited States, Korea, Republic of, Chile, Canada
-
BayerActive, not recruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited States
-
Dizal PharmaceuticalsActive, not recruitingNon-Small Cell Lung CancerKorea, Republic of, Spain, United States, France, Taiwan, Italy, China, Argentina, Australia, Malaysia, Canada, Japan, Chile
-
AstraZenecaDaiichi Sankyo Co., Ltd.CompletedGastric or Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
University College, LondonBoehringer IngelheimCompletedNon-small Cell Lung CancerUnited Kingdom
-
Byondis B.V.CompletedSolid TumorsNetherlands, Belgium, United Kingdom, Spain
-
Spectrum Pharmaceuticals, IncTerminated
-
AC Camargo Cancer CenterTerminatedTrastuzumab to Patients With Advanced Gastric Cancer With HER2 Positive Expression in CTC (GASTHER2)Gastric Cancer Stage IVBrazil
-
Pieris Pharmaceuticals, Inc.Active, not recruitingHER2-positive Gastric CancerUnited States, Korea, Republic of
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.CompletedColorectal NeoplasmUnited States, Spain, Japan, Italy, United Kingdom
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Cancer Hospital; First Affiliated Hospital of Zhejiang University; Sir... and other collaboratorsUnknownColorectal CancerChina
-
RemeGen Co., Ltd.CompletedAdvanced Cancer | Urothelial CarcinomaChina
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedGlioblastoma Multiforme (GBM)United States
-
Tongji UniversityUnknownNon-small Cell Lung CancerChina
-
Genentech, Inc.Completed
-
NYU Langone HealthWithdrawnStomach Cancer | Esophageal CancerUnited States
-
Cancer Trials IrelandCompletedBreast Cancer | HER2 Positive Breast Cancer | HER2 Negative Breast CancerIreland
-
MacroGenicsApproved for marketingHER2-positive Breast Cancer | HER2-positive Carcinoma
-
Ambrx, Inc.WithdrawnHER2 Mutation-Related Tumors | HER2 Amplified Solid TumorsUnited States
-
Amunix, a Sanofi CompanyMerck Sharp & Dohme LLCRecruitingLocally Advanced or Metastatic HER2-Expressing CancersAustralia, Spain, France, Portugal
-
H. Lee Moffitt Cancer Center and Research InstituteThe Shulas' FoundationRecruitingTriple Negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Sichuan UniversityRecruitingPleural Effusion, Malignant | Peritoneal Carcinoma MetastaticChina
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...Recruiting
-
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.Shenzhen Second People's HospitalUnknown
-
Nantes University HospitalTerminatedRelapsed/Refractory LeukemiaFrance
-
su haichuanNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterNovartisCompleted
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
Duke UniversityNational Cancer Institute (NCI)CompletedBreast Cancer | Gastric Cancer | Ovarian CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); PfizerTerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Breast Carcinoma Metastatic in the BrainUnited States
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | Breast Neoplasm | Carcinoma, Ductal, BreastUnited Kingdom, Bulgaria, Georgia, Moldova, Republic of
-
Triumvira Immunologics, Inc.Merck Sharp & Dohme LLCTerminatedHER2 Positive Gastric Cancer | Metastatic HER2 Positive Gastroesophageal Junction CancerUnited States, Canada
-
Consorzio OncotechCompleted
-
University of WashingtonNational Cancer Institute (NCI); National Center for Complementary and Integrative...CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | HER2/Neu PositiveUnited States
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; iOMEDICO AGCompletedHer2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast CancerGermany
-
NRG OncologyNational Cancer Institute (NCI); Alliance for Clinical Trials in Oncology; Eastern... and other collaboratorsRecruitingHER2-positive Breast CancerUnited States, Puerto Rico
-
Roswell Park Cancer InstituteUnited States Department of DefenseRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Metastatic Malignant Neoplasm in the BrainUnited States
-
Molecular Templates, Inc.TerminatedHER2-positive Solid CancersUnited States, Australia, New Zealand
-
Seagen Inc.CompletedTriple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast NeoplasmsUnited States
-
Shanghai Miracogen Inc.RecruitingAdvanced Solid TumorChina
-
Spectrum Pharmaceuticals, IncSuspended
-
Second Military Medical UniversityUnknown
-
Jazz PharmaceuticalsALX Oncology Inc.Active, not recruitingHER2-expressing CancersUnited States